Provided by Tiger Trade Technology Pte. Ltd.

Provident

22.58
+0.23001.03%
Post-market: 22.580.00000.00%19:30 EDT
Volume:945.16K
Turnover:21.31M
Market Cap:2.95B
PE:9.42
High:22.69
Open:22.51
Low:22.39
Close:22.35
52wk High:25.49
52wk Low:17.69
Shares:130.62M
Float Shares:126.13M
Volume Ratio:1.01
T/O Rate:0.75%
Dividend:0.96
Dividend Rate:4.25%
EPS(TTM):2.40
EPS(LYR):2.23
ROE:11.14%
ROA:1.25%
PB:1.01
PE(LYR):10.12

Loading ...

AR3 PFS Confirms Koppamurra as High-Return Rare Earths Project

TIPRANKS
·
Jun 25

American West advances PFS and permitting at strategic Storm copper project in Nunavut

TIPRANKS
·
Jun 24

American West closes in on Canadian copper development decision

The West Australian
·
Jun 24

True North eyes bigger Qld Cloncurry copper comeback prize

The West Australian
·
Jun 24

Provident Financial Services Names Adriano Duarte as CFO

MT Newswires Live
·
Jun 23

Provident Bank Appoints Adriano Duarte Evp and Chief Financial Officer

THOMSON REUTERS
·
Jun 23

Press Release: Provident Bank Appoints Adriano Duarte EVP and Chief Financial Officer

Dow Jones
·
Jun 23

Regis Resources Reports Nearly 1.9 Million Ounce Reinstated Ore Reserve at McPhillamys Gold Project, Shares Down 3%

MT Newswires Live
·
Jun 19

True North bags neighbouring deposit to supercharge QLD copper play

The West Australian
·
Jun 18

Provident Bank Announces $1 Million in Grants to Ten New Jersey Non-Profit Organizations

GlobeNewswire
·
Jun 17

Turaco Gold Highlights Afema PFS and Maiden 1.9Moz Ore Reserve in Côte d’Ivoire

TIPRANKS
·
Jun 17

Turaco Gold’s Afema PFS Confirms Strong Economics for 200,000oz-a-Year Ivory Coast Mine

TIPRANKS
·
Jun 17

Provident Financial Services’ George Lista, Pres/CEO Prov Protection Plus, disposes of 3,528 common shares for $82,575.48

Reuters
·
Jun 16

Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress

GlobeNewswire
·
Jun 15

Genmab Announces Epcoritamab Monotherapy and Epcoritamab-Based Combination Regimens Demonstrate High Response Rates in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

GlobeNewswire
·
Jun 14

Genmab Presents EPCORE® FL-1 Subgroup Data Demonstrating Consistent Efficacy and Safety Results for Epcoritamab in Combination with Rituximab and Lenalidomide (R2) Across Relapsed or Refractory (R/R) Follicular Lymphoma (FL) Patients

GlobeNewswire
·
Jun 11

Theriva™ Biologics Announces Results from VCN-01 Phase 1 Clinical Trial in Head and Neck Cancer Published in Clinical Cancer Research

GlobeNewswire
·
Jun 11

New Partner Emerges for RAS Inhibitors in Treating the "King of Cancers"

Deep News
·
Jun 09

U.S. RESEARCH ROUNDUP- Apple, Lennar, Toll Brothers

Reuters
·
Jun 09

Stephens Initiates Provident Financial Services With Equalweight Rating, $24 Price Target

MT Newswires Live
·
Jun 09